blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP4248897

EP4248897 - SYSTEMS AND METHODS FOR TREATING CANCER AND/OR AUGMENTING ORGAN FUNCTION [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  27.06.2024
Database last updated on 29.10.2024
FormerThe application has been published
Status updated on  25.08.2023
Most recent event   Tooltip28.06.2024Amendment by applicant 
Applicant(s)For all designated states
Autonomix Medical, Inc.
6420 Bayview Place
Excelsior, MN 55331 / US
[2023/39]
Inventor(s)01 / TOTH, Landy
Doylestown, 18901 / US
02 / SCHWARTZ, Robert S
Inver Grove Heights, 55076 / US
 [2023/39]
Representative(s)Page White Farrer
Bedford House
21a John Street
London WC1N 2BF / GB
[2023/39]
Application number, filing date23171646.503.12.2015
[2023/39]
Priority number, dateUS201462087629P04.12.2014         Original published format: US 201462087629 P
[2023/39]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP4248897
Date:27.09.2023
Language:EN
[2023/39]
Type: A3 Search report 
No.:EP4248897
Date:27.12.2023
Language:EN
[2023/52]
Search report(s)(Supplementary) European search report - dispatched on:EP29.11.2023
ClassificationIPC:A61B18/14, A61N7/02, A61K45/06, A61K31/045, A61B5/388, A61B5/00
[2023/52]
CPC:
A61B18/082 (EP); A61B18/06 (EP); A61B5/388 (EP);
A61B5/4041 (EP); A61B5/4884 (EP); A61B5/6851 (EP);
A61K31/045 (EP); A61K45/06 (EP); A61B18/1492 (EP);
A61B2018/0022 (EP); A61B2018/00267 (EP); A61B2018/00333 (EP);
A61B2018/00404 (EP); A61B2018/00434 (EP); A61B2018/00482 (EP);
A61B2018/00511 (EP); A61B2018/00529 (EP); A61B2018/00547 (EP);
A61B2018/00559 (EP); A61B2018/00577 (EP); A61B2018/00642 (EP);
A61B2018/00702 (EP); A61B2018/00744 (EP); A61B2018/00791 (EP);
A61B2018/00827 (EP); A61B2018/00839 (EP); A61B2018/00875 (EP);
A61B2018/0212 (EP); A61B2018/1425 (EP); A61B2018/143 (EP);
A61B2018/1861 (EP); A61B2562/0204 (EP); A61B2562/0247 (EP);
A61B5/01 (EP); A61B5/14503 (EP); A61B5/24 (EP);
A61B5/318 (EP); A61B5/389 (EP); A61N1/36017 (EP);
A61N7/022 (EP) (-)
Former IPC [2023/39]A61B18/14, A61N7/02, A61K45/06, A61K31/045
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2024/31]
Former [2023/39]AL,  AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MK,  MT,  NL,  NO,  PL,  PT,  RO,  RS,  SE,  SI,  SK,  SM,  TR 
TitleGerman:SYSTEME UND VERFAHREN ZUR BEHANDLUNG VON KREBS UND/ODER VERSTÄRKUNG DER ORGANFUNKTION[2023/39]
English:SYSTEMS AND METHODS FOR TREATING CANCER AND/OR AUGMENTING ORGAN FUNCTION[2023/39]
French:SYSTÈMES ET MÉTHODES DE TRAITEMENT DU CANCER ET/OU D'AUGMENTATION DE LA FONCTION D'UN ORGANE[2023/39]
Examination procedure27.06.2024Amendment by applicant (claims and/or description)
27.06.2024Examination requested  [2024/31]
27.06.2024Date on which the examining division has become responsible
Parent application(s)   TooltipEP15865545.6  / EP3226759
Fees paidRenewal fee
04.05.2023Renewal fee patent year 03
04.05.2023Renewal fee patent year 04
04.05.2023Renewal fee patent year 05
04.05.2023Renewal fee patent year 06
04.05.2023Renewal fee patent year 07
04.05.2023Renewal fee patent year 08
12.12.2023Renewal fee patent year 09
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[X]WO2013112844  (TOTH LANDY [US], et al) [X] 1-12 * abstract * * paragraphs [0006] - [0008] - [0 23] - [0024] - [0 98] - [0100] - [ 180] , [ 259] - [0260] *;
 [I]WO2014089553  (TOTH LANDY [US]) [I] 1-12 * abstract * * paragraphs [0177] , [ 195] , [ 252] - [0254] * * the whole document *;
 [IP]WO2015057696  (AUTONOMIX MEDICAL INC [US]) [IP] 1-12 * paragraphs [0096] - [0098] - [ 123] - [0124] ** the whole document *
by applicantUS5945403
 WO2013042847
 WO2013067726
 WO2013112844
 WO2013181137
 WO2014031962
 WO2014070999
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.